There are several basic approaches that can be utilized when conducting economic evaluations for any new health care intervention; which can include medications that are designed for the treatment and prevention of disease and how to relate the effectiveness with the overall monetary value of the new treatment. The economic tools that can be employed to perform such an analysis can be broken down into four basic parts that consist of cost-minimization analysis (CMA), cost-effectiveness analysis
population is urba... ... middle of paper ... ...imary health care approach. BMC Family Practice, 13(1), 67-70. Gavaza, P., Rascati, K., Oladapo, A., & Khoza, S. (2012). The state of health economic research in South Africa: a systematic review. Pharmacoeconomics, 30(10), 925-940. Jooste, K., & Jasper, M. (2012). A South African perspective: current position and challenges in health care service management and education in nursing. Journal Of Nursing Management, 20(1), 56-64. Klopper, H. C., Coetzee
Direct-to-consumer (DTC) marketing of pharmaceuticals has grown increasingly in the past decade. The American public views prescription drug advertising for a wide range of medical conditions, including high cholesterol, depression, allergies, and erectile dysfunction. The Federal Food and Drug Administration (FDA) regulates the content of these advertisements. Critics also have taken the position that the advertisements garner unearned trust from the public, are misleading, and promote unnecessary
The organizations that use contracts may make use of more than one contract. The contracting process could segregate pharmaceuticals from consultants. The segregation permits renegotiations for a specific purpose. Consultant services generally incorporate policy and procedure updates related to state and federal regulatory compliance, quality assurance programs, and staff education. The contracts may update professional services as it relates to a change in populations. The inclusion of a sub-acute
McLaughlin, C. & McLaughlin, C. (2008). Health policy analysis: An interdisciplinary approach. Boston, MA: Jones and Bartlett Publishers. Petrou, S., & Wolstenholme, J. (2000). A review of alternative approaches to healthcare resource allocation. Pharmacoeconomics, 18(1), 33-43.
Stimulating pharmaceutical innovation in the EU. Expert Review of Pharmacoeconomics & Outcomes Research, 2011. 11(3): p. 235-239. 5. Baker D, Fugh-Berman A. Do New Drugs Increase Life Expectancy? A Critique of a Manhattan Institute Paper. Journal of General Internal Medicine. 2009;24(5):678-682. doi:10.1007/s11606-009-0954-4
Hospital acquired urinary track infections associated with the indwelling catheter. Urology Clinic of North America, 26(4), 821-828. Stone, P. (2009). Economic burden of healthcare-associated infections: an American perspective. Expert Review Of Pharmacoeconomics & Outcomes Research, 9(5), 417-422. doi:10.1586/erp.09.53 Sundvall, P., Ulleryd, P., & Gunnarsson, R. (2011). Urine culture doubtful in determining etiology of diffuse symptoms among elderly individuals: a cross-sectional study of 32 nursing